CRIS Current Research Information System

PARCHI, PIERO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.987
AS - Asia 12.872
EU - Europa 9.037
SA - Sud America 904
AF - Africa 602
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 3
Totale 36.430
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.798
SG - Singapore 3.539
VN - Vietnam 3.268
CN - Cina 3.169
GB - Regno Unito 2.304
IT - Italia 1.944
DE - Germania 1.188
HK - Hong Kong 990
SE - Svezia 663
BR - Brasile 641
FR - Francia 629
IN - India 580
UA - Ucraina 444
RU - Federazione Russa 440
KR - Corea 344
IE - Irlanda 333
NL - Olanda 329
JP - Giappone 246
FI - Finlandia 191
SC - Seychelles 174
ZA - Sudafrica 170
EE - Estonia 137
CI - Costa d'Avorio 118
ID - Indonesia 114
AR - Argentina 106
CA - Canada 91
JO - Giordania 80
PH - Filippine 73
MX - Messico 72
AT - Austria 67
IQ - Iraq 66
BD - Bangladesh 64
BG - Bulgaria 62
TR - Turchia 59
TH - Thailandia 56
CH - Svizzera 50
ES - Italia 46
EC - Ecuador 43
TG - Togo 42
BE - Belgio 38
DK - Danimarca 35
PL - Polonia 35
CO - Colombia 31
TW - Taiwan 31
PK - Pakistan 25
UZ - Uzbekistan 25
SA - Arabia Saudita 24
AU - Australia 21
CL - Cile 20
VE - Venezuela 20
NG - Nigeria 19
GR - Grecia 18
LT - Lituania 16
PY - Paraguay 16
LB - Libano 15
MA - Marocco 15
MY - Malesia 15
TN - Tunisia 14
IL - Israele 13
IR - Iran 12
PE - Perù 12
EG - Egitto 11
CZ - Repubblica Ceca 10
DZ - Algeria 9
KE - Kenya 9
AL - Albania 8
UY - Uruguay 8
DO - Repubblica Dominicana 7
RO - Romania 7
AZ - Azerbaigian 6
HU - Ungheria 6
OM - Oman 6
AE - Emirati Arabi Uniti 5
BA - Bosnia-Erzegovina 5
CR - Costa Rica 5
KZ - Kazakistan 5
SY - Repubblica araba siriana 5
AM - Armenia 4
AO - Angola 4
BH - Bahrain 4
GA - Gabon 4
HR - Croazia 4
KH - Cambogia 4
PT - Portogallo 4
SK - Slovacchia (Repubblica Slovacca) 4
BO - Bolivia 3
BY - Bielorussia 3
ET - Etiopia 3
HN - Honduras 3
KG - Kirghizistan 3
KW - Kuwait 3
LU - Lussemburgo 3
LV - Lettonia 3
LY - Libia 3
MN - Mongolia 3
NP - Nepal 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BZ - Belize 2
Totale 36.387
Salva come PNG Salva come JPEG
Città #
Singapore 2.449
Southend 1.986
Ashburn 1.330
Fairfield 1.227
Hong Kong 946
Chandler 795
Hefei 746
Ho Chi Minh City 665
Woodbridge 613
Houston 610
San Jose 604
Seattle 597
Dong Ket 580
Hanoi 554
Wilmington 548
Ann Arbor 522
Cambridge 466
Bologna 435
Princeton 424
Beijing 336
Dublin 333
Santa Clara 320
Seoul 300
Dallas 298
Boardman 291
Jacksonville 268
Lauterbourg 266
Council Bluffs 210
Tokyo 204
Los Angeles 195
Nanjing 177
Westminster 171
Berlin 157
Padova 138
Turin 135
Redmond 134
Helsinki 128
Milan 128
Abidjan 118
Buffalo 110
Redondo Beach 99
Haiphong 97
Florence 94
Da Nang 93
Jinan 87
New York 86
Shenyang 85
San Diego 83
Bengaluru 82
Frankfurt am Main 81
Amman 80
Guangzhou 73
Changsha 67
São Paulo 67
Jakarta 65
Saint Petersburg 65
Chicago 64
Des Moines 58
Sofia 57
Tianjin 56
Medford 55
Nuremberg 55
Rome 54
Hebei 52
Nanchang 52
Shanghai 51
Lappeenranta 50
Mülheim 49
Lomé 42
London 42
Falls Church 41
Can Tho 39
Olalla 39
Imola 37
Verona 37
Vienna 37
Brussels 36
Amsterdam 35
Phoenix 34
Hangzhou 33
Biên Hòa 31
Dearborn 30
Jiaxing 30
Zhengzhou 30
Montreal 28
Bern 27
Toronto 27
Yubileyny 27
Mahé 26
Hải Dương 25
Mexico City 25
Norwalk 25
Taiyuan 25
Baghdad 24
Redwood City 23
Warsaw 23
Fuzhou 22
Johannesburg 22
Quận Bình Thạnh 22
Wuhan 22
Totale 23.437
Salva come PNG Salva come JPEG
Nome #
Human prion diseases in the Netherlands (1998-2009): clinical, genetic and molecular aspects. 512
Cerebrospinal fluid biomarkers of neurodegeneration in narcolepsy type 1 408
The Bologna motor and non-motor prospective study on parkinsonism at onset (BoProPark): study design and population 353
Anterior Callosal Angle: A New Marker of Idiopathic Normal Pressure Hydrocephalus? 291
Messenger RNA processing is altered in autosomal dominant leukodystrophy 278
Diagnostic value of plasma p-tau181, NfL, and GFAP in a clinical setting cohort of prevalent neurodegenerative dementias 271
Predicting conversion from mild cognitive impairment to Alzheimer's disease using brain 1 H-MRS and volumetric changes: A two- year retrospective follow-up study 262
Cerebral Mitochondrial Microangiopathy Leads to Leukoencephalopathy in Mitochondrial Neurogastrointestinal Encephalopathy 260
Abnormal ADC in the brain of prion disease patients: variation between brain structures. 240
Analysis of RNA Expression Profiles Identifies Dysregulated Vesicle Trafficking Pathways in Creutzfeldt-Jakob Disease 240
A case of fatal familial insomnia in Africa. 237
A CTNNA3 compound heterozygous deletion implicates a role for αT-catenin in susceptibility to autism spectrum disorder. 230
High diagnostic value of second generation CSF RT-QuIC across the wide spectrum of CJD prions 224
Sporadic fatal insomnia in a fatal familial insomnia pedigree. 222
Analysis of Conformational Stability of Abnormal Prion Protein Aggregates across the Spectrum of Creutzfeldt-Jakob Disease Prions 222
Diagnostic-prognostic value and electrophysiological correlates of CSF biomarkers of neurodegeneration and neuroinflammation in amyotrophic lateral sclerosis 221
A prospective evaluation of clinical and instrumental features before and after ventriculo-peritoneal shunt in patients with idiopathic Normal pressure hydrocephalus: The Bologna PRO-Hydro study 220
CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia 219
Performance of a seed amplification assay for misfolded alpha-synuclein in cerebrospinal fluid and brain tissue in relation to Lewy body disease stage and pathology burden 213
Maternally inherited genetic variants of CADPS2 are present in Autism Spectrum Disorders and Intellectual Disability patients. 211
Cognitive profile in idiopathic autonomic failure: relation with white matter hyperintensities and neurofilament levels 209
A second case of Gerstmann-Sträussler-Scheinker disease linked to the G131V mutation in the prion protein gene in a Dutch patient. 207
Muscle ceroid lipofuscin-like deposits in a patient with corticobasal syndrome due to a progranulin mutation 206
Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and A$\upbeta$42 levels 205
Age at onset in genetic prion disease and the design of preventive clinical trials 205
Age at onset of genetic (E200K) and sporadic Creutzfeldt-Jakob diseases is modulated by theCYP4X1gene 203
Diagnostic Accuracy of a Combined Analysis of Cerebrospinal Fluid t-PrP, t-tau, p-tau, and Aβ42 in the Differential Diagnosis of Creutzfeldt-Jakob Disease from Alzheimer's Disease with Emphasis on Atypical Disease Variants 198
Characterization of novel progranulin gene variants in Italian patients with neurodegenerative diseases 198
Atypical Creutzfeldt-Jakob disease with PrP-amyloid plaques in white matter: molecular characterization and transmission to bank voles show the M1 strain signature 194
ADC and Proton Spectroscopy Reflect Cellular Pathology in Patients with Creutzfeldt-Jakob Disease 193
"Agrypnia excitata'' in a case of sporadic Creutzfeldt-Jakob disease VV2 192
An atypical phenotype of CJD associated with the E200K mutation in the prion protein gene. 188
Clinical effects of Lewy body pathology in cognitively impaired individuals 187
In vivo assessment of Lewy body and beta-amyloid copathologies in idiopathic normal pressure hydrocephalus: prevalence and associations with clinical features and surgery outcome 187
Clinical Reasoning: Rapidly progressive dementia in a patient with HIV after an exotic journey 186
Cerebrospinal fluid biomarkers in patients with frontotemporal dementia spectrum: A single-center study 186
Quantifying prion disease penetrance using large population control cohorts 185
The First Historically Reported Italian Family with FTD/ALS Teaches a Lesson on C9orf72 RE: Clinical Heterogeneity and Oligogenic Inheritance 185
Coexistence of Both PrPSc Type 1 and 2 in sCJD: Does it Affect the Phenotype? 184
Detection of prions in skin punch biopsies of Creutzfeldt–Jakob disease patients 184
Sporadic Creutzfeldt-Jakob Disease. 181
Effects of different experimental conditions on the PrPSc core generated by protease digestion: implications for strain typing and molecular classification of CJD. 181
Agent strain variation in human prion disease: insights from a molecular and pathological review of the National Institutes of Health series of experimentally transmitted disease. 181
Identification of rare genetic variants in Italian patients with dementia by targeted gene sequencing 181
Elevated plasma p-tau181 levels unrelated to Alzheimer's disease pathology in amyotrophic lateral sclerosis 179
Two novel PRNP truncating mutations broaden the spectrum of prion amyloidosis 175
An in vivo proton magnetic resonance spectroscopy study of thalamus in prion disease 174
Reduced in Vivo thalamic N-Acetyl-Aspartate is a Diagnostic Marker of Prion Disease 171
Analyses of Protease Resistance and Aggregation State of Abnormal Prion Protein across the Spectrum of Human Prions 171
Characterization of truncated forms of abnormal prion protein in Creutzfeldt-Jakob disease. 171
La risonanza magnetica di diffusione differenzia la degenerazione corticobasale dalla paralisi sopranucleare progressiva e dalla malattia di Parkinson. 171
Pearls & Oy-sters: rapidly progressive dementia: prions or immunomediated? 171
Neurofilament light chain and α-synuclein RT-QuIC as differential diagnostic biomarkers in parkinsonisms and related syndromes 171
The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias 170
Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies 170
Narcolepsy is a common phenotype in HSAN IE and ADCA-DN 169
Distribution of Diffusivity Changes in Subcortical Deep Gray Matter in Prion Diseases 168
Antemortem CSF Aβ42/Aβ40 ratio predicts Alzheimer's disease pathology better than Aβ42 in rapidly progressive dementias 167
Diagnostic and Prognostic Value of Plasma GFAP in Sporadic Creutzfeldt-Jakob Disease in the Clinical Setting of Rapidly Progressive Dementia 166
CSF α-synuclein seed amplification kinetic profiles are associated with cognitive decline in Parkinson’s disease 166
Genomic, transcriptomic and RNA editing analysis of human MM1 and VV2 sporadic Creutzfeldt-Jakob disease 164
Incidence and spectrum of sporadic Creutzfeldt-Jakob disease variants with mixed phenotype and co-occurrence of PrP(Sc) types: an updated classification. 163
PROTEIN AMYLOIDOSIS ASSOCIATED WITH A NOVEL STOP CODON MUTATION IN PRNP 162
Phenotypic variability of sporadic human prion disease and its molecular basis: past, present, and future. 162
Sporadic Fatal Insomnia in Europe: Phenotypic features and diagnostic challenges 162
Revisiting the Cerebrospinal Fluid Biomarker Profile in Idiopathic Normal Pressure Hydrocephalus: The Bologna Pro-Hydro Study 162
Comparison between plasma and cerebrospinal fluid biomarkers for the early diagnosis and association with survival in prion disease 162
History and state of the art of PrP-res “typing” in Creutzfeldt-Jakob disease 161
Multiorgan detection and characterization of protease-resistant prion protein in a case of variant CJD examined in the United States. 161
Transmission properties of atypical Creutzfeldt-Jakob disease: A clue to disease etiology? 161
The characterization of AD/PART co-pathology in CJD suggests independent pathogenic mechanisms and no cross-seeding between misfolded Aβ and prion proteins 161
Clinicopathological features of the rare form of Creutzfeldt-Jakob disease in R208H-V129V PRNP carrier 160
Pre-symptomatic diagnosis in fatal familial insomnia: serial neurophysiological and 18FDG-PET studies 158
Variably protease-sensitive prionopathy presenting within ALS/FTD spectrum 158
Prion protein amyloidosis with divergent phenotype associated with two novel nonsense mutations in PRNP. 158
Heterogeneity of truncated fragments distinct from PrP27-30 correlates with clinico-pathological subtypes of Creutzfeldt-Jakob disease 157
Pathologic correlates of diffusion MRI changes in Creutzfeldt-Jakob disease 157
Alpha-synuclein seed amplification assay longitudinal outcomes in Lewy body disease spectrum 156
Magnetic resonance diagnostic markers in clinically sporadic prion disease: a combined brain magnetic resonance imaging and spectroscopy study. 156
Use of in vivo proton magnetic resonance spectroscopy in the differential diagnosis of prion diseases 155
Rapidly Progressive Alzheimer’s Disease: Contributions to Clinical-Pathological Definition and Diagnosis 154
Regional pattern of microgliosis in sporadic Creutzfeldt-Jakob disease in relation to phenotypic variants and disease progression 154
Identification of recurrent genetic patterns from targeted sequencing panels with advanced data science: a case-study on sporadic and genetic neurodegenerative diseases 154
Revisiting the Heidenhain Variant of Creutzfeldt-Jakob Disease: Evidence for Prion Type Variability Influencing Clinical Course and Laboratory Findings 153
Iodine-123-meta-iodobenzylguanidine myocardial scintigraphy in isolated autonomic failure: Potential red flag for future multiple system atrophy 153
Atypical neuropathological sCJD-MM phenotype with abundant white matter Kuru-type plaques sparing the cerebellar cortex. 152
Prion protein misfolding, strains, and neurotoxicity: an update from studies on Mammalian prions. 152
Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease 151
Effects of Formalin Fixation, Paraffin Embedding, and Time of Storage on DNA Preservation in Brain Tissue: A BrainNet Europe Study 150
Genetic Creutzfeldt-Jakob disease and fatal familial insomnia: Insights into phenotypic variability and disease pathogenesis. 150
Unusual Clinical Presentations Challenging the Early Clinical Diagnosis of Creutzfeldt-Jakob Disease 150
Agrypnia Excitata 150
Prion disease: an in vivo proton magnetic resonance spectroscopy study of thalamus. 149
CJD Associated with the E200K Mutation with Valine at Codon 129 on the Mutated Allele and Methionine on the Wild Type Allele: Report of Two Cases 148
Towards an improved early diagnosis of neurodegenerative diseases: The emerging role of in vitro conversion assays for protein amyloids 148
RT-QuIC Detection of Pathological α-Synuclein in Skin Punches of Patients with Lewy Body Disease 148
Early onset sleep disorders predict severity, progression and death in multiple system atrophy 148
Analysis of polymorphisms in PRNP 5' UTR region in sCJD subtypres 147
Towards an early clinical diagnosis of sporadic CJD VV2 (ataxic type) 147
4-Repeat tau seeds and templating subtypes as brain and CSF biomarkers of frontotemporal lobar degeneration 147
Totale 18.871
Salva come PNG Salva come JPEG
Categoria #
all - tutte 100.588
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.588
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.379 0 0 0 0 0 0 0 0 0 173 135 1.071
2021/20223.709 348 137 248 179 347 209 86 354 177 309 729 586
2022/20233.873 430 489 161 486 284 284 141 217 679 100 392 210
2023/20241.223 74 185 109 131 131 142 54 112 47 103 75 60
2024/20255.048 207 793 376 361 625 264 386 127 113 416 230 1.150
2025/202613.093 1.256 1.598 1.531 1.118 1.469 748 1.400 587 2.415 971 0 0
Totale 37.231